Clinical Trial Update: Yttrium Microspheres With Cetuximab Plus Irinotecan for Patients With Advanced Colorectal Cancer Mets to Liver [Phase 2]

View source ↗

Summary

A Phase 2 trial investigating Yttrium-90 microspheres combined with cetuximab and irinotecan for advanced colorectal cancer with liver metastases has been withd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• Irinotecan (Irinotecan)
• Yttrium-90 microspheres (yttrium-90 microspheres)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Colon Cancer, Colorectal Cancer | Phase 2 | Status: WITHDRAWN